Table 5 Types of biomarkers for AIT

1. Identification and validation of biomarkers assessing the probability of response to treatment of AIT before it is initiated

2. Identification and validation of biomarkers assessing the safety of AIT before it is initiated

3. Identification and validation of biomarkers confirming the efficacy of AIT in patients receiving AIT (short and long term)

4. Identification and validation of biomarkers predicting the long-term effects of AIT before it is stopped

5. Identification and validation of biomarkers predicting the relapse of symptoms when AIT is stopped